Eagle Capital Growth Fund
GRF · NYSE American
About GRF
- Employees
- 0
- Headquarters
- Milwaukee, Wisconsin
- Listed
- Jul 13, 2001
- Sector
- N/A
- Industry
- N/A
- Website
- eaglecapitalgrowthfund.com
GRF key statistics
- Market cap
- 40.17M
- Price-earnings ratio
- 7.87
- Dividend yield
- —
- Average volume
- 2.15K
- Volume
- 34
- Open price
- $9.96
- High today
- $9.97
- Low today
- $9.97
- 52 Week high
- $11.85
- 52 Week low
- $9.56
Eagle Capital Growth Fund (GRF) at a glance
Eagle Capital Growth Fund (GRF) last traded at $9.97, with a market cap of 40.17M and a price-to-earnings ratio of 7.87.
Volume so far is 34 shares, below the average of 2.15K shares a day.
Over the past year Eagle Capital Growth Fund has ranged from $9.56 to $11.85, and now sits 18% of the way up that range.
GRF news
- Press releaseBusiness Wire
- Press releaseBusiness Wire
Eagle Capital Growth Fund Declares Year-End Distribution of $0.68 Per Share in Cash
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.